SUNHO BIO-B(02898): Delay in publishing annual performance for 2025.

SUNHO BIO-B (02898) announces that, in accordance with Rule 13.49(1) of the Listing Rules, the company must publish its annual performance announcement within 3 months after the end of the company's financial year (i.e. by March 31, 2026) for the year 2025. According to Rule 13.49(2) of the Listing Rules, the preliminary announcement of the 2025 annual performance must be based on the financial statements for the financial year ending on December 31, 2025, which must be approved by the company's auditors. The Board of Directors hereby announces that they have received notification from the company's auditors that they are still gathering documents and information to complete the annual audit for the year ending on December 31, 2025, and additional time and resources are needed to complete the audit for the year 2025. Based on the above circumstances, the Board foresees that the company will not be able to publish the 2025 annual performance as required by Rule 13.49(1) of the Listing Rules. As of the date of this announcement, the company is actively cooperating with the auditors and assisting in completing the unfinished procedures for the 2025 annual audit. Rule 13.49(3) of the Listing Rules stipulates that if an issuer is unable to publish preliminary results, it must disclose its performance based on unaudited financial performance (to the extent available) that has not been agreed upon with the auditors. After careful consideration, the Board believes it is inappropriate to disclose the unaudited management accounts of the group for the year ending on December 31, 2025 at this stage, as they may not accurately reflect the financial performance and condition of the group, potentially leading to unnecessary confusion for shareholders and potential investors. According to Rule 13.50 of the Listing Rules, if an issuer fails to publish regular financial information in accordance with the Listing Rules, the Stock Exchange will typically require trading in the issuer's securities to be suspended until the issuer publishes the required financial information. Therefore, it is currently expected that trading in the company's shares will be suspended on the Stock Exchange starting at 9:00 am on April 1, 2026, until the company publishes its 2025 annual performance.